This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Fosun Pharma Sets Final 2025 Dividend and Withholding Tax Terms for H-Share Investors

Tipranks - Tipranks - Wed Jun 17, 9:16AM CDT

Claim 55% Off TipRanks

Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) has provided an update.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has declared a final ordinary cash dividend of RMB 0.39 per share for the financial year ended 31 December 2025, with approval obtained on 16 June 2026. For H-share holders registered in Hong Kong, the dividend will be paid in Hong Kong dollars at HKD 0.45 per share, based on an exchange rate of RMB 1 to HKD 1.1503.

The company has set an ex-dividend date of 16 July 2026, with the book closure period running from 20 to 24 July and a record date of 24 July, ahead of a scheduled payment on 14 August 2026. Fosun Pharma detailed differentiated withholding tax arrangements for non-resident enterprise and individual shareholders, as well as mainland investors using Stock Connect, clarifying after-tax entitlements and reinforcing regulatory compliance for cross-border investors.

The most recent analyst rating on (HK:2196) stock is a Buy
with a HK$35.30 price target.
To see the full list of analyst forecasts on Shanghai Fosun Pharmaceutical (Group) Co stock,
see the HK:2196 Stock Forecast page.

More about Shanghai Fosun Pharmaceutical (Group) Co

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based healthcare company engaged in the research, development, manufacturing and distribution of pharmaceutical products and medical services. The group is listed in Hong Kong and serves both domestic and international markets, providing investors with exposure to the Chinese pharmaceutical and healthcare sector.

Average Trading Volume: 2,829,489

Technical Sentiment Signal: Sell

Current Market Cap: HK$63.91B

Learn more about 2196 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).